Advantest Corporation (ATEYY)

Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	50,844	31,708	33,279	16,828	15,314	17,174
Market Cap Growth	83.30%	-4.72%	97.76%	9.89%	-10.83%	114.64%
Enterprise Value	49,625	31,019	33,373	16,649	14,640	16,255
Last Close Price	68.19	44.13	44.58	23.16	19.81	22.25
PE Ratio	32.25	29.46	80.81	17.16	21.30	27.22
PS Ratio	8.11	6.09	10.35	3.99	4.46	6.07
PB Ratio	12.77	9.37	11.67	6.07	6.31	6.78
P/TBV Ratio	14.73	11.09	15.13	8.20	8.88	8.41
P/FCF Ratio	25.66	17.68	384.95	46.91	30.12	34.28
P/OCF Ratio	24.04	16.60	154.08	31.86	23.57	28.00
EV/Sales Ratio	8.17	5.96	10.38	3.95	4.26	5.75
EV/EBITDA Ratio	21.31	16.79	43.24	11.71	13.71	23.30
EV/EBIT Ratio	23.04	18.61	55.70	13.20	15.50	26.33
EV/FCF Ratio	25.05	17.30	386.04	46.41	28.80	32.44
Debt / Equity Ratio	0.16	0.19	0.22	0.14	0.15	0.04
Debt / EBITDA Ratio	0.26	0.34	0.81	0.27	0.34	0.15
Debt / FCF Ratio	0.32	0.35	7.22	1.07	0.70	0.21
Asset Turnover	1.12	1.02	0.77	1.02	0.91	0.80
Inventory Turnover	1.71	1.62	1.29	1.83	2.27	2.34
Quick Ratio	1.45	1.21	1.55	1.07	1.32	2.30
Current Ratio	2.26	1.94	3.33	2.15	2.02	3.11
Return on Equity (ROE)	44.12%	34.38%	15.57%	39.32%	30.37%	27.27%
Return on Assets (ROA)	24.86%	20.45%	8.91%	19.14%	15.63%	10.96%
Return on Capital (ROIC)	32.89%	27.71%	11.99%	27.67%	22.75%	15.95%
Return on Capital Employed (ROCE)	52.40%	45.80%	16.60%	39.40%	33.40%	20.50%
Earnings Yield	3.10%	3.40%	1.24%	5.83%	4.70%	3.67%
FCF Yield	3.90%	5.66%	0.26%	2.13%	3.32%	2.92%
Dividend Yield	0.37%	0.59%	0.51%	1.10%	1.25%	1.20%
Payout Ratio	12.62%	16.95%	39.94%	19.49%	29.16%	22.35%
Buyback Yield / Dilution	0.33%	0.11%	1.43%	3.83%	1.60%	0.34%
Total Shareholder Return	0.70%	0.70%	1.93%	4.93%	2.84%	1.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.